Lipitor vs. Vytorin

See how Lipitor and Vytorin compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Lipitor is a standalone statin, while Vytorin combines a statin with a cholesterol absorption inhibitor for added LDL lowering.

  • Both drugs are taken once daily as oral tablets, but Vytorin's simvastatin component carries stricter dose-related myopathy warnings.

  • Lipitor has been available generically since 2011, while Vytorin remains a brand-only fixed-dose combination.

Lipitor vs. Vytorin Drug Summary

Lipitor

Lipitor (atorvastatin) is an HMG-CoA reductase inhibitor, or statin, used to lower LDL cholesterol and reduce cardiovascular risk in adults and certain children. It is taken as a single oral tablet once daily, with doses ranging from 10 mg to 80 mg. It has been available generically since 2011.

Vytorin

Vytorin combines ezetimibe, a cholesterol absorption inhibitor, with simvastatin, a statin, in one tablet to lower LDL cholesterol more than either drug alone. It is taken once daily, with combined doses ranging from 10/10 mg to 10/80 mg. It remains available only as a brand-name combination product.

Lipitor vs. Vytorin Side Effects

Lipitor

Most common
Nasopharyngitis (up to 8.3%)
Arthralgia (up to 6.9%)
Diarrhea (up to 6.8%)
Pain in extremity (up to 6.0%)

Vytorin

Most common
Headache (up to 5.8%)
Increased ALT (up to 3.7%)
Myalgia (up to 3.6%)
Diarrhea (up to 2.8%)

Lipitor vs. Vytorin Dosage

Lipitor

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 80 mg once daily If needed
Dose changes 3 increases As tolerated

Vytorin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg/10 mg once daily At the start
Maximum dose 10 mg/80 mg once daily If needed
Dose changes 3 increases As tolerated

Lipitor vs. Vytorin Indications

Lipitor

Lipitor is FDA-approved to lower LDL cholesterol and triglycerides in adults and children age 10 and older with dyslipidemia. It also reduces the risk of heart attack, stroke, and certain heart procedures in adults with multiple cardiovascular risk factors, including those with type 2 diabetes. It is approved for both heterozygous and homozygous familial hypercholesterolemia.

  • Lowers LDL cholesterol and triglycerides in adults and children 10+

  • Reduces heart attack and stroke risk in high-risk adults

  • Reduces cardiovascular risk in adults with type 2 diabetes

  • Treats homozygous and heterozygous familial hypercholesterolemia

Vytorin

Vytorin is FDA-approved to lower LDL cholesterol, total cholesterol, triglycerides, and Apo B in adults with primary hyperlipidemia, while also raising HDL. It is approved for homozygous familial hypercholesterolemia and homozygous sitosterolemia. In the IMPROVE-IT trial, it reduced major cardiovascular events compared with simvastatin alone in patients after a heart attack or unstable angina.

  • Lowers LDL, total cholesterol, triglycerides, and Apo B

  • Raises HDL cholesterol in adults with hyperlipidemia

  • Treats homozygous familial hypercholesterolemia

  • Treats homozygous sitosterolemia

Lipitor vs. Vytorin Pros and Cons

Lipitor

Lipitor is a well-studied, single-ingredient statin with decades of safety data and no boxed warning. As a generic, it is widely covered by insurance and available at low out-of-pocket cost. Because it works through one mechanism, dosing decisions are more straightforward than with combination therapy.

Pros

  • More than two decades of real-world safety data

  • No boxed warning, unlike some other lipid therapies

  • Single-ingredient dosing is simpler to adjust

  • Approved for use in children as young as 10

Cons

  • Works through only one cholesterol-lowering pathway

  • Higher doses carry increased myopathy risk

  • Not approved for sitosterolemia or Apo B lowering claims

  • May need higher doses for maximal LDL reduction

Vytorin

Vytorin combines two cholesterol-lowering mechanisms in one tablet, which can produce greater LDL reduction than a statin alone, especially in patients who don't reach goal on a statin by itself. It carries additional restrictions, including contraindication with strong CYP3A4 inhibitors and a capped simvastatin dose due to myopathy risk. As a brand-only combination, it is not available as a generic fixed-dose product.

Pros

  • Combines two mechanisms for greater LDL lowering

  • Backed by the IMPROVE-IT cardiovascular outcomes trial

  • Also approved for homozygous sitosterolemia

  • Single tablet combines two drug classes

Cons

  • Not available as a generic fixed-dose combination

  • Contraindicated with strong CYP3A4 inhibitors

  • 80 mg simvastatin dose restricted due to myopathy risk

  • Higher risk of hypersensitivity reactions like angioedema

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.